Literature DB >> 10066225

Register cannot replace prospective studies in sickle cell disease.

A Yardumian, A Olujohungbe, K Cinkotai.   

Abstract

Mesh：

Year:  1999        PMID： 10066225      PMCID： PMC1115108          DOI： 10.1136/bmj.318.7184.671a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  European register of patients with sickle cell disease treated with hydroxyurea is being set up.

Authors:  S C Davies; M Roberts-Harwood
Journal:  BMJ       Date:  1998-08-22

2.  Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.

Authors:  A Olujohungbe; K I Cinkotai; A Yardumian
Journal:  BMJ       Date:  1998-06-06

3.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.